Home/Filings/4/0001453687-22-000020
4//SEC Filing

Kishimoto Takashi Kei 4

Accession 0001453687-22-000020

CIK 0001453687other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:34 PM ET

Size

7.0 KB

Accession

0001453687-22-000020

Insider Transaction Report

Form 4
Period: 2022-01-03
Kishimoto Takashi Kei
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2022-01-03+72,000271,769 total
  • Award

    Employee Stock Option (right to buy)

    2022-01-03+340,000340,000 total
    Exercise: $3.31Exp: 2032-01-02Common Stock (340,000 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 3, 2023. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 3, 2026.
  • [F2]This option vests as to 25% on January 3, 2023. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.

Issuer

SELECTA BIOSCIENCES INC

CIK 0001453687

Entity typeother

Related Parties

1
  • filerCIK 0001676930

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:34 PM ET
Size
7.0 KB